Search PubMedSearch

Biomedical subjects

G Benrubi

Publications and source records attributed to G Benrubi.

11 recordsLinked to original sources

Vulvar and vaginal hematomas: a retrospective study of conservative versus operative management.

We reviewed 32 cases of vulvar and vaginal hematomas treated at three hospitals in Jacksonville, Florida, from March 1975 to March 1985. Patients ranged in age from 14 to 37 years. In 29 patients the hematomas resulted from obstetric trauma and in three from other causes. We found that patients managed conservatively had more subsequent operative intervention and more complications requiring antibiotics and transfusion, and they required more days of hospitalization than patients managed operatively. We also found an increased risk of complications and increased hospitalization for patients with conservatively managed hematomas when the product of the longitudinal diameter and the transverse diameter was 15 or greater.

Adolescent

Cefonicid vs. cefoxitin for cesarean section prophylaxis.

A randomized, prospective study compared a long-acting, second-generation cephalosporin, cefonicid (Monocid), with a short-acting, second-generation cephalosporin, cefoxitin (Mefoxin), for cesarean section prophylaxis. One hundred thirty-nine patients were enrolled, with 81 receiving a 1-g intravenous dose of cefonicid after cord clamping and 58 receiving a 2-g dose of intravenous cefoxitin after cord clamping and at 6, 12 and 18 hours postpartum. In those patients receiving cefonicid prophylaxis, endometritis incidence was 17.3% (14 of 81). This finding was not statistically significant (P less than .397) when compared to the 12.1% incidence of endometritis (7 of 58) with cefoxitin. In addition, the febrile morbidity incidence for cefonicid prophylaxis was 23.5% (19 of 81) as compared to 15.5% (9 of 58) for cefoxitin (P less than .25). Because the two drugs appear to be equally efficacious, cefonicid may be the better choice because of its markedly lower cost.

Adult

Stromal and peripheral eosinophilia in cervical carcinoma.

One hundred cases of Stage IB cervical carcinoma treated with radical hysterectomy and pelvic lymphadenectomy at University Hospital of Jacksonville, Florida between 1973 and 1982. Eight patients were found to have tumor stromal eosinophilia on pathology review. Thirteen patients showed eosinophilia in their peripheral smears. Statistical analysis did not reveal a significant recurrence rate in patients with either peripheral or stromal eosinophilia.

Adult